Skip to main content
SpringerLink
Log in
Book cover

Fundamentals of Cancer Pain Management pp 97–105Cite as

Opioid-Related Side Effects and Management

Part of the Cancer Treatment and Research book series (CTAR,volume 182)

Abstract

The following areas will be discussed in relation to opioid-related side effects and approaches to their management in the cancer patient:

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Dunlop GM (1989) A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far advanced cancer. Palliative Med 4:37–43

    CrossRef  Google Scholar 

  2. Herndon CM, Jackson KC 2nd, Hallin PA (2002) Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmaco-Therapy 22:240–250

    CrossRef  CAS  Google Scholar 

  3. Porreca F et al (2009) Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options. Pain Med 10(4): 654–662. https://doi.org/10.1111/j.1526-4637.2009.00583.x. Epub 19 Mar 2009

  4. Rousseau P (1996) Non-pain symptom management in terminal care. Clin Geriatr Med 12:313–327

    CrossRef  CAS  Google Scholar 

  5. Sande TA, Laird BJA, Fallon MT (2019) The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review. J Palliat Med 22(1):90–97. https://doi.org/10.1089/jpm.2018.0260

    CrossRef  PubMed  Google Scholar 

  6. Cortés-Flores AO, Jiménez-Tornero J, Morgan-Villela G et al (2018) Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: results of a controlled clinical trial. Eur J Cancer Care (Engl) 27(1). https://doi.org/10.1111/ecc.12686

  7. Tsukuura H, Miyazaki M, Morita T et al (2018) Efficacy of prophylactic treatment for oxycodone-induced nausea and vomiting among patients with cancer pain (POINT): a randomized, placebo-controlled double-blind trial. Oncologist 23(3):367–374. https://doi.org/10.1634/theoncologist.2017-0225

    CrossRef  CAS  PubMed  Google Scholar 

  8. Woron J et al (2016) The role of naloxegol in the management of opioid-induced bowel dysfunction. Therap Adv Gastroenterol 9(5):736–746

    CrossRef  Google Scholar 

  9. Mori T et al (2013) Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions. J Pharmacol Exp Ther 347(1):91–99. https://doi.org/10.1124/jpet.113.204313 Epub 2013 Jul 31

    CrossRef  CAS  PubMed  Google Scholar 

  10. Tuteja AK et al (2010) Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain. Neurogastroenterol Motil 22: 424–430, e96

    Google Scholar 

  11. Coluzzi F, Pappagallo M (2005) Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol 71:425–433

    CAS  PubMed  Google Scholar 

  12. Camilleri M (2011) Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 106:835–842

    CrossRef  CAS  Google Scholar 

  13. Webster LR (2015) Opioid-Induced Constipation. Pain Med 16(Suppl 1):S16-21. https://doi.org/10.1111/pme.12911

    CrossRef  PubMed  Google Scholar 

  14. Clark K, Currow DC (2013) Constipation in palliative care: what do we use as definitions and outcome measures? J Pain Symptom Manage 45:753–762

    CrossRef  Google Scholar 

  15. Peppin JF, Robinson A (2012) What is opioid-induced constipation? Spine Universe. Updated June 29, 2012. Available at http://www.spineuniverse.com/treatments/medication/what-opioid-induced-consti-pation. Accessed June 2015

  16. Caraceni A, Hanks G, Kaasa S et al (2012) Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 13:e58-68

    CrossRef  CAS  Google Scholar 

  17. Streicher et al (2017) Peripherally acting μ-opioid receptor antagonists for the treatment of opioid-related side effects: mechanism of action and clinical implications. J Pharm Pract 2017 Sep 25, 897190017732263. https://doi.org/10.1177/0897190017732263

  18. Relistor. Package Insert. Bridgewater NJ Salix Pharmaceuticals, Inc. 2019

    Google Scholar 

  19. Wang CZ et al (2013) Pharmacologic treatment of opioid-induced constipation. Expert Opin Investig Drugs 22(10):1225–1227. https://doi.org/10.1517/13543784.2013.819341 Epub 2013 Jul 9

    CrossRef  CAS  PubMed  Google Scholar 

  20. Mehta N et al (2016) Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review. Postgrad Med 128(3):282–289. https://doi.org/10.1080/00325481.2016.1149017 Epub 2016 Feb 23

    CrossRef  PubMed  Google Scholar 

  21. Lipman AG et al (2011) Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study. J Pain Palliat Care Pharmacother 25(2):136–145. https://doi.org/10.3109/15360288.2011.573531

    CrossRef  PubMed  Google Scholar 

  22. Rauck RL (2013) Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone. Drugs 73(12):1297–1306. https://doi.org/10.1007/s40265-013-0084-5

    CrossRef  CAS  PubMed  Google Scholar 

  23. Movantik. Package Insert. Raleigh NC RedHill biopharma Inc. 2020

    Google Scholar 

  24. Yoon SC, Bruner HC (2017) Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem. Patient Prefer Adherence 11: 1265–1271. https://doi.org/10.2147/PPA.S99412. Published 24 Jul 2017

  25. Els C, Jackson TD, Kunyk D et al (2017) Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev 10(10): CD012509. https://doi.org/10.1002/14651858.CD012509.pub2. Published 30 Oct 2017

  26. Chuang TK, Killam KF, Chuang LF, Kung HF, Sheng WS, Chao CC, Yu L, Chuang RY (1995) Mu opioid receptor gene expression in immune cells. Biochem Biophys Res Commun 216:922–930 (PubMed: 7488213)

    CrossRef  CAS  Google Scholar 

  27. Sharp BM, Roy S, Bidlack JM (1998) Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol 83:45–56 (PubMed: 9610672)

    CrossRef  CAS  Google Scholar 

  28. Suzuki M, Sakurada T, Gotoh K, Watanabe S, Satoh N (2013) Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain. Am J Hosp Palliat Care 30:712–716

    CrossRef  Google Scholar 

  29. Shou J, Zhang Z, Lai Y, Chen Z, Huang J (2016) Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs: a systematic review and meta-analysis. BMC Cancer 16:687

    CrossRef  Google Scholar 

  30. Mathew B, Lennon FE, Siegler J, Mirzapoiazova T, Mambetsariev N, Sammani S et al (2011) The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg 112:558–567

    CrossRef  CAS  Google Scholar 

  31. PDQ Supportive and Palliative Care Editorial Board (2019) PDQ Cancer Pain—Health Professional Version. National Cancer Institute, Bethesda, MD. https://www.cancer.gov/

  32. Leppert W (2015) Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Des Devel Ther 9: 2215–2231. https://doi.org/10.2147/DDDT.S32684. eCollection 2015

  33. Webster L et al (2014) Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther 40(7):771–779. https://doi.org/10.1111/apt.12899 Epub 2014 Aug 12

    CrossRef  CAS  PubMed  Google Scholar 

  34. about-cancer/treatment/side-effects/pain/pain-hp-pdq. Accessed 17 April 2019

    Google Scholar 

  35. CDC guidelines for opioid prescribing

    Google Scholar 

  36. Mitchell MT (2019) Dancing with deterrents: understanding the role of abuse-deterrent opioid formulations and naloxone in managing cancer pain. Oncologist. 2019 May 31. pii: theoncologist, 2019-0340. https://doi.org/10.1634/theoncologist.2019-0340

  37. Howlett C et al (2016) Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain. J Oncol Pharm Pract 22(1):114–120. https://doi.org/10.1177/1078155214551589 Epub 2014 Sep 16

    CrossRef  CAS  PubMed  Google Scholar 

  38. Ryan SA et al (2018) Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review. Pain Manag 8(3):231–245. https://doi.org/10.2217/pmt-2017-0060 Epub 2018 Apr 23

    CrossRef  PubMed  Google Scholar 

  39. https://www.jpsmjournal.com/article/S0885-3924(03)00250-1/pdf

Download references

Author information

Authors and Affiliations

  1. UCLA Department of Anesthesiology and Perioperative Medicine, 757 Westwood Plaza #3325, Los Angeles, CA, 90095, USA

    Andrea Poon

  2. UCLA Department of Anesthesiology and Perioperative Medicine, Los Angeles, CA, USA

    Jakun Ing & Eric Hsu

Authors
  1. Andrea Poon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jakun Ing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Poon .

Editor information

Editors and Affiliations

  1. Departments of Supportive Care Medicine and Anesthesiology, City of Hope National Medical Center, Duarte, CA, USA

    MD Andrew Leitner

  2. New York, NY, USA

    MD Christine Chang

Rights and permissions

Reprints and Permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Poon, A., Ing, J., Hsu, E. (2021). Opioid-Related Side Effects and Management. In: Leitner, A., Chang, C. (eds) Fundamentals of Cancer Pain Management. Cancer Treatment and Research, vol 182. Springer, Cham. https://doi.org/10.1007/978-3-030-81526-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81526-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81525-7

  • Online ISBN: 978-3-030-81526-4

  • eBook Packages: MedicineMedicine (R0)

search

Navigation